Status:
COMPLETED
a Small Dose of Naloxone,Minimize Intrathecal Morphine Side Effects
Lead Sponsor:
Assiut University
Conditions:
Post-Op Complication
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
I.V naloxone decreases incidence and severity of the common morphine side effects (pruritis, nausea/emesis, constipation, urinary retention, respiratory depression and undesirable sedation) so using i...
Detailed Description
Bupivacaine hydrochloride is a commonly used local anesthetic in spinal anesthesia, however, the duration of spinal analgesia by bupivacaine is limited to about 75-150 minutes, therefore, various addi...
Eligibility Criteria
Inclusion
- ASA physical status I - II
- undergoing anal surgery with spinal anesthesia
Exclusion
- Renal ,hepatic and cardiac patients -Infection at the site of injection.-
- Coagulopathy or other bleeding diathesis. -Preexisting neurologic deficits.-
- History of hypersensitivity to any of the given the drugs.
- Inability to communicate with the investigator and the hospital staff.
- History of chronic opioid use.
Key Trial Info
Start Date :
May 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03230474
Start Date
May 1 2016
End Date
April 1 2017
Last Update
October 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emad Zarief Kamel Said
Asyut, Egypt, 71111